Compare MOGU & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOGU | BNGO |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.8M | 24.3M |
| IPO Year | 2018 | 2018 |
| Metric | MOGU | BNGO |
|---|---|---|
| Price | $2.48 | $1.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 6.9K | ★ 192.4K |
| Earning Date | 11-21-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $19,462,964.00 | ★ $28,720,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.83 | $1.45 |
| 52 Week High | $8.10 | $22.80 |
| Indicator | MOGU | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 41.90 | 40.14 |
| Support Level | $2.39 | $1.61 |
| Resistance Level | $2.71 | $1.63 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 19.57 | 9.52 |
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.